Edition:
United States

Ra Pharmaceuticals Receives Development Milestone Payment Under Agreement With Merck


Thursday, 6 Dec 2018 07:30am EST 

Dec 6 (Reuters) - Ra Pharmaceuticals Inc ::RA PHARMACEUTICALS RECEIVES DEVELOPMENT MILESTONE PAYMENT UNDER AGREEMENT WITH MERCK.RA PHARMACEUTICALS INC - RECEIVED A DEVELOPMENT MILESTONE PAYMENT UNDER ITS COLLABORATION AGREEMENT WITH MERCK, KNOWN AS MSD OUTSIDE US AND CANADA.RA PHARMACEUTICALS INC - CO ELIGIBLE TO EARN UP TO $59 MILLION IN ADDITIONAL MILESTONE PAYMENTS FROM MERCK.RA PHARMACEUTICALS - ALSO ELIGIBLE TO RECEIVE LOW-TO-MID SINGLE DIGIT PERCENTAGE ROYALTIES ON FUTURE SALES OF COMPOUNDS RESULTING FROM COLLABORATION.